Scientific Evidence We are presenting at the 2024 American Thyroid Association Annual Meeting - Chicago, IL October 30 - November 3, 2024 - Come see us! LEARN MORE Prognostication with Thyroid GuidePx in the context of tall cell variants Read More > Abstract: RAI GuidePx: A robust predictor for radioactive iodine sensitivity status in papillary thyroid cancer leveraging thyroid differentiation genes. Read More > Abstract: Molecular subtypes in radiation induced papillary thyroid cancer using Thyroid GuidePx. Read More > A clinically useful and biologically informative genomic classifier for papillary thyroid cancer [2023] Read More > Improved Risk Stratification for Papillary Thyroid Cancer (PTC) using a genomic classifier informed by clinical features [2022] Read More > Molecular subgroups identified by machine learning enable accurate prognostication of papillary thyroid cancer [2021] Read More > READ MORE Prognostication with Thyroid GuidePx in the context of tall cell variants Abstract: RAI GuidePx: A robust predictor for radioactive iodine sensitivity status in papillary thyroid cancer leveraging thyroid differentiation genes. Abstract: Molecular subtypes in radiation induced papillary thyroid cancer using Thyroid GuidePx. The Technological Drivers Powering Precision Oncology Unique Thyroid Cancer Tests: New Hope Unveiled Understanding Radioactive Iodine Resistance in Thyroid Cancer: Overcoming Treatment Challenges
Abstract: RAI GuidePx: A robust predictor for radioactive iodine sensitivity status in papillary thyroid cancer leveraging thyroid differentiation genes.